Top 3 Health Care Stocks That Are Set To Fly This Quarter
Top 3 Health Care Stocks That Are Set To Fly This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
医疗保健板块中最超卖的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指标是一种动量指标，它比较了股票在价格上涨时的强度与在价格下跌时的强度。与股票的价格走势进行比较，可以给交易者更好的了解股票短期内表现的良好程度。当RSI低于30时，资产通常被认为是超卖的，根据Benzinga Pro的数据。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行业板块最近的主要超卖股票列表，RSI接近或低于30。
BIMI Holdings Inc (NASDAQ:BIMI)
BIMI控股有限公司（纳斯达克：BIMI）
- On May 20, BIMI announced the receipt of a delinquency compliance alert notice from Nasdaq. The company's stock fell around 68% over the past five days and has a 52-week low of $0.24.
- RSI Value: 24.62
- BIMI Price Action: Shares of BIMI Holdings closed at $0.42 on Wednesday.
- Benzinga Pro's charting tool helped identify the trend in DXCM stock.
- 5月20日，BIMI宣布收到纳斯达克的不合规警示通知。该公司股价在过去5天内下跌了约68％，52周内最低价为0.24美元。
- RSI值：24.62
- BIMI控股股票周三收盘价为0.42美元。
- Benzinga Pro的图表工具帮助识别DXCm股票的趋势。
Edwards Lifesciences Corp (NYSE:EW)
爱德华生命科学公司（纽约证券交易所：EW）
- On July 24, Edwards Lifesciences reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.. The company's stock fell around 30% over the past month. It has a 52-week low of $58.93.
- RSI Value: 22.55
- EW Price Action: Shares of Edwards Lifesciences closed at $63.05 on Wednesday.
- Benzinga Pro's real-time newsfeed alerted to latest EW news.
- 7月24日，爱德华生命科学公司报告第二季度销售收入低于预期，并发出低于预期的第三季度指导。此外，该公司收购了JenaValve和Endotronix。该公司股价在过去一个月内下跌了约30％，52周最低价为58.93美元。
- RSI值：22.55
- 爱德华生命科学股票周三收盘价为63.05美元。
- Benzinga Pro的实时新闻提醒了最新的爱德华生命科学资讯。
Merck & Co Inc (NYSE:MRK)
默克（纽约证券交易所：MRK）
- Merck reported better-than-expected second-quarter earnings and sales results on Tuesday. The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The company's shares fell around 12% over the past month and has a 52-week low of $99.14.
- RSI Value: 28.20
- MRK Price Action: Shares of Merck rose 0.1% to close at $113.13 on Wednesday.
- 默克公司周二报告了超出市场预期的第二季度盈利和销售业绩。该公司发布了161亿美元的季度销售额，同比增长了7％，超过了市场预期的158.4亿美元。不计入外汇影响，销售额增长了11％。默克公司报告了每股调整后的盈利为2.28美元，而不是预期的每股收益亏损2.06美元，超过市场预期的2.15美元。该公司股价在过去一个月内下跌了约12％，52周最低价为99.14美元。
- RSI值：28.20
- 默沙东股票周三上涨了0.1％，收于113.13美元。
Read More:
阅读更多：
- Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear & Greed Index Now In 'Neutral' Zone As Investor Sentiment Improves
- 纳斯达克收盘于较高点，英伟达创下自2月以来的最佳交易日：恐惧与贪婪指数现处于"中立"区域，投资者情绪得到改善。
